Folic Acid (Folate, Vitamin B9) Tablets - Uses, Dose, Brand Names

Folic Acid (Folate) or vitamin B 9 is an essential vitamin that is required for nucleic acid synthesis, erythropoiesis, and as a cofactor for methanol toxicity. It is recommended in pregnant women for organogenesis and to reduce the incidence of neural tube defects (spina bifida).

Folic Acid (Folate) Uses:

  • Megaloblastic and macrocytic anemias due to folate deficiency:

    • It is indicated for the treatment of megaloblastic anemia due to folate deficiency.
  • Off Label Use of Folic Acid in Adults:

    • As an alternative to leucovorin calcium (calcium folinate), it may be used as an adjunctive cofactor therapy in methanol toxicity.
    • It is indicated in pregnant women at high risk of giving birth to babies with neural tube defects
    • It may be used as a supplement to reduce toxicity associated with antifolate chemotherapy.

Folic Acid (Folate) Dose in Adults

Folic Acid (Folate) Dose in the treatment of Megaloblastic and macrocytic anemias due to folate deficiency:

  • 1 to 5 mg orally once a day.
  • Doses up to 15 mg once a day may be given in severe cases.
  • Manufacturer's labeling:

    • Oral, IM, IV, SubQ: Initial:
      • 0.4 to 1 mg/day.
    • Maintenance dose:
      • 4 mg/day
  • Pregnant and lactating women:
    • Maintenance dose of 0.8 mg/day

Folic Acid (Folate) Dose in the treatment of Methanol poisoning (off-label):

  • 50 to 70 mg intravenous every four hours or
  • 50 mg orally every 3 to 4 hours.
  • Folic acid treatment should continue until the complete elimination of methanol and formic acid.
  • It should never be used as monotherapy. Cofactors are adjunctive to antidotal therapy.

Folic Acid (Folate) Dose in the Prevention of neural tube defects (off-label):

  • Females of childbearing potential:

    • 4 mg/day orally daily or
    • 0.4 to 0.8 mg/day.
    • Folate supplementation should be initiated at least one month prior to conception and continue until at least 12 weeks of gestation.
  • Females at high risk, those with a family history of neural tube defects, or those who have had a previous pregnancy with a neural tube defect:

    • 4 mg/day orally.
    • Folic acid supplementation should be initiated at least 3 months before conception and continued until at least the 12 weeks of gestation.

Folic Acid (Folate) Dose as Supplementation to reduce toxicity associated with antifolate chemotherapy (off-label): 

  • To reduce toxicity associated with pemetrexed:

    • Give folic acid 0.35 to 1 mg once a day. Initiate folic acid treatment 1 to 3 weeks before initiating pemetrexed treatment.
    • Continue for three weeks after the last dose of pemetrexed.
    • Administer folic acid with intramuscular cyanocobalamin supplementation.
  • To reduce toxicity associated with pralatrexate:

    • Give folic acid 1 to 1.25 mg once a day.
    • Beginning folate supplementation at least 10 days before initiating pralatrexate treatment.
    • The treatment must be continued for 30 days after the last pralatrexate dose.
    • It should be administered with intramuscular cyanocobalamin supplementation.

Folic Acid (Folate) Dose in Childrens

Adequate intake (AI) of Folic Acid (Folate): 

  • 1-6 months:

    • 65 mcg/day
  • 7-12 months:

    • 80 mcg/day

Recommended daily allowance (RDA) of Folic Acid (Folate):

  • 1-3 years:

    • 150 mcg/day
  • 4-8 years:

    • 200 mcg/day
  • 9-13 years:

    • 300 mcg/day
  • Adolescents ≥14 years:

    • 400 mcg/day

Folic Acid (Folate) Dose in the treatment of Anemia (folic acid deficiency):

Oral, IM, IV, SubQ:

  • Infants:

    • 1 mg/day
  • Children <4 years:

    • Up to 0.3 mg/day
  • Children >4 years and Adolescents:

    • 4 mg/day

Folic Acid (Folate) Dose in the maintenance requirement of folic acid as Parenteral nutrition:

Intravenous administration:

  • Infants:

    • 56 mcg/kg/day
  • Children and Adolescents younger than 13 years:

    • 140 mcg/day
  • Adolescents older than 13 years:

    • 400 mcg/day

Folic Acid (Folate) Dose in the prevention of Gingival hyperplasia due to phenytoin:

  • Children ≥6 years and Adolescents:

    • 5 mg/day orally.

Folic Acid (Folate) use in Pregnancy (Pregnancy Risk Category: A)

 

  • Folic Acid (Folate), a water-soluble vitamin, can cross the placental boundary. Pregnancy is when maternal needs increase.
  • Folic acid is a preventive measure that reduces the risk of neural tube defects (spina bifida).
  • Folate supplementation should be started before any female patient plans to get pregnant.
  • Spina-bifida is a condition in which a woman's risk of having a baby with a neural tube defect (spina bifida), should be taken at higher doses.
  • Folate supplementation is required for pregnant women with folate deficiency.

Folic acid use during breastfeeding:

  • Folic Acid (Folate), which is found in human breastmilk, is an essential nutrient. Breastfeeding women have a higher daily intake.
  • Except faor severe deficiencies, maternal concentrations are not affected.

Folic Acid (Folate) Dose in Kidney Disease:

Dose adjustment in not recommended in patients with kidney disease.

Folic Acid (Folate) Dose in Liver disease:

Dose adjustment is not recommended in patients with liver disease.

Side effects of Folic Acid (Folate):

  • Cardiovascular:

    • Flushing (slight)
  • Central nervous system:

    • Malaise (general)
  • Dermatologic:

    • Erythema
    • Pruritus
    • Skin rash
  • Hypersensitivity:

    • Hypersensitivity reaction
  • Respiratory:

    • Bronchospasm

Contraindications to Folic Acid (Folate):

Allergy reactions to folic acids or any other component of the formulation

Warnings and precautions

  • Monotherapy for Anemia

    • Patients with pernicious anemia, aplastic anemia, and normocytic encephalopathy should avoid it as a monotherapy.
  • Pernicious anemia:

    • While irreversible nerve damage is possible, doses exceeding 0.1 mg/day can obscure the symptoms of pernicious Anemia.

Folic acid: Drug Interaction

Risk Factor C (Monitor therapy)

Capecitabine

Folic Acid may enhance the adverse/toxic effect of Capecitabine.

Floxuridine

Folic Acid may enhance the adverse/toxic effect of Floxuridine.

Fluorouracil (Systemic)

Folic Acid may enhance the adverse/toxic effect of Fluorouracil (Systemic).

Fosphenytoin

Folic Acid may decrease the serum concentration of Fosphenytoin.

Green Tea

May decrease the serum concentration of Folic Acid.

PHENobarbital

Folic Acid may decrease the serum concentration of PHENobarbital.

Phenytoin

Folic Acid may decrease the serum concentration of Phenytoin.

Primidone

Folic Acid may decrease the serum concentration of Primidone. Additionally, folic acid may decrease concentrations of active metabolites of primidone (e.g., phenobarbital).

SulfaSALAzine

May decrease the serum concentration of Folic Acid.

Tegafur

Folic Acid may enhance the adverse/toxic effect of Tegafur.

Risk Factor D (Consider therapy modification)

Pyrimethamine

Folic Acid may diminish the therapeutic effect of Pyrimethamine. Management: Folic acid doses greater than 2.5 mg per day should be avoided due to the potential for sulfadoxine/pyrimethamine treatment failure. Consider limiting folic acid use to no more than 0.4 mg per day for women of child-bearing age.

Sulfadoxine

Folic Acid may diminish the therapeutic effect of Sulfadoxine. Management: Folic acid doses greater than 2.5 mg per day should be avoided due to the potential for sulfadoxine/pyrimethamine treatment failure. Consider limiting folic acid use to no more than 0.4 mg per day for women of child-bearing age.

Risk Factor X (Avoid combination)

Raltitrexed

Folic Acid may diminish the therapeutic effect of Raltitrexed.

 

Monitoring parameters:

  • Monitor for rising blood counts in patients with folate deficiency anemias.
  • Observe for neurological signs if administered to patients with macrocytic anemia.
  • Avoid folate administration in patients with vitamin B12 deficiency as it may worsen the neurological features associated with vitamin B12 deficiency.

How to administer Folic Acid (Folate)?

  • It should preferably be administered per oral.
  • However, it can also be administered by a deep Intramuscular injection, SubQ, and intravenous injections.

Intravenous administration:

  • Doses 5 mg or less may be administered undiluted over greater than one minute
  • It may be administered after dilution in 50 ml NS or 5% DW and infused over 30 minutes.
  • Dilution is recommended for doses greater than 5 mg.
  • It may also be added to intravenous solutions and given as an intravenous infusion.

Mechanism of action of Folic Acid (Folate):

  • Folic acid is essential for many co-enzymes involved in metabolic pathways. 
  • Folic acid is essential for the synthesis and use of pyrimidine and purines, as well as nucleoproteins and erythropoiesis.
  • Folate deficiency patients also benefit from the stimulation of platelets, WBCs and other metabolic processes.
  • Folic acid is helpful in the conversion of toxic metabolites of methanol (formic acids) to non-toxic substances in methanol poisoning.

The onset of action:

  • Peak effect is seen when administered Orally: 0.5 to 1 hour

Absorption:

  • It is absorbed in the proximal part of the small intestine

Metabolism:

  • Hepatic

Bioavailability of oral folate:

  • Folic acid supplement: about 100%
  • In the presence of food: 85%
  • Dietary folate: 50%

Time to peak serum concentration after oral administration:

  • One hour

Excretion:

  • Urine

International Brands of Folic Acid (Folate):

  • FA-8
  • JAMP-Folic Acid
  • NOVO-Folacid
  • SANDOZ Folic Acid
  • F. Valdecasas
  • Acfol
  • Acide Folique CCD
  • Acido Folico
  • Acido Folico Fada
  • Acifol
  • Anemolat
  • Apo-Folic
  • Bio-Folic
  • Clonfolic
  • Conacid
  • Elvefocal
  • Endofolin
  • Enhansid
  • Feri
  • Filicine
  • Fionat
  • Folac
  • Folacid
  • Folacin
  • Folart
  • Folate
  • Folavit
  • Folbiol
  • Folcid
  • Folee-1
  • Foli 5
  • Foliage
  • Foliamin
  • Folic Acid DHA
  • Folic Acid Pharm Ecologist
  • Folicap
  • Folicid
  • Folicil
  • Folicum
  • Folimax
  • Folimen
  • Folimet
  • Folin
  • Folina
  • Folinsyre ”Dak”
  • Foliphar
  • Folitab
  • Folivit
  • Folivita
  • Folivital
  • Foloicare
  • Folsan
  • Folsyre
  • Folverlan
  • Folvit
  • Folvite
  • Gravi-Fol
  • Gravida
  • Huma-Folacid
  • Ingafol
  • Lexpec
  • Megafol
  • Mithra Folic
  • Nufolic
  • Obstetra
  • Prinac AC
  • Quatro
  • RubieFol
  • Tecnovorin
  • Tesha-1
  • Tifol
  • Tonixan
  • Travital Folic Acid
  • Vifolin

Folic acid (Folate) Brand Names in Pakistan:

Folic Acid Syrup 0.35 mg

G-Tose Glitz Pharma
Hiron Goodman Laboratories

 

Folic Acid Tablets 5 mg

Deefol Delux Chemical Industries
Delfol Delta Pharma (Pvt) Ltd.
Folacin Pharmedic (Pvt) Ltd.
Folic Eros Pharmaceuticals
Folic Acid Geofman Pharmaceuticals
Folic Acid Karachi Pharmaceutical Laboratory
Folic Acid Geofman Pharmaceuticals
Folic Acid Zafa Pharmaceutical Laboratories (Pvt) Ltd.
Folic Acid Chas. A. Mendoza
Folic Acid Albro Pharma
Folic Acid Zephyr Pharmatec (Pvt) Ltd.
Folic Acid Shaheen Agencies
Folic Acid Karachi Pharmaceutical Laboratory
Folic Acid Chas. A. Mendoza
Folic Acid Irza Pharma (Pvt) Ltd.
Folic Acid Zephyr Pharmatec (Pvt) Ltd.
Folic Acid Semos Pharmaceuticals (Pvt) Ltd.
Folic Acid Albro Pharma
Folimic Alliance Pharmaceuticals (Pvt) Ltd.
Folitab Nabiqasim Industries (Pvt) Ltd.
Hasfol Hassan Pharmaceuticals (Pvt) Ltd.
Staiflic Standard Drug Co.
Zal Alson Pharmaceuticals

 

Folic Acid Tablets 0.35 mg

Megatron Plus Rotex Medica Pakistan (Pvt) Ltd
Politoose -F Karachi Pharmaceutical Laboratory
Polytos-F Miracle Pharmaceuticals(Pvt) Ltd

 

Folic Acid Capsules 5 mg

Afna-Vit Jafson Pharmaceuticals (Pvt) Ltd.

 

Folic Acid Capsule 0.35 mg

Ferovel Well & Well Pharma (Pvt) Ltd

Comments

NO Comments Found